IL-33 appears to be one of the main factors that increase early during the disease course in SSc (34), mainly induced by activated endothelial cells (22, 35), thus linking its pro-fibrogenic properties to the vascular disarrangement of the disease (14). This evidence concerns the gene IL33 and systemic sclerosis.